CN105664094A - Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention - Google Patents
Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention Download PDFInfo
- Publication number
- CN105664094A CN105664094A CN201610043474.3A CN201610043474A CN105664094A CN 105664094 A CN105664094 A CN 105664094A CN 201610043474 A CN201610043474 A CN 201610043474A CN 105664094 A CN105664094 A CN 105664094A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- parts
- postpartum
- application
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses application of a pharmaceutical composition to preparation of an externally-applied medicine for treating postpartum urinary retention.The pharmaceutical composition is prepared from traditional Chinese medicinal materials including Cortex Magnoliae Officinalis, Fructus Gardeniae, Fructus Sophorae, Rhizoma Zingiberis and Radix Morindae Officinalis.The pharmaceutical composition is extremely remarkable in curative effect on postpartum urinary retention and simple, convenient and feasible in application.In addition, hospitalization days are shortened, and accordingly physical pains as well as economic burdens are relieved for patients.
Description
The application is point case application of the application for a patent for invention (denomination of invention is: a kind of pharmaceutical composition treating uroschesis in postpartum, and application number is: 2014100707991, and the applying date is: on February 28th, 2014) that applicant Cui Xinming proposes.
Technical field
The invention belongs to Chinese materia medica nursing technique field, it is specifically related to the application of a kind of pharmaceutical composition in the externally applied medicine of preparation treatment puerpera's uroschesis in postpartum.
Background technology
Postpartum, uroschesis was the common complication of obstetrics, incidence 7%-10%. Postpartum, uroschesis referred to that 6-8h filling of bladder in postpartum can not Self-discharged urine, generation misnicturition and row's urine retention. Postpartum, puerpera was once generation uroschesis, and full bladder compressing uterus, causes uterine contraction bad, postpartum hemorrhage occur. The hemorrhage anxiety of puerpera, impact feed and sleep, and poor sleep affects the secretion of breast amount, makes puerpera can not accomplish lactation as required, affects growing of newborn infant; In addition, because misnicturition in postpartum causes spirit nervous, it is easy to bring out mental disorder. So, postpartum should emptying bladder as early as possible, reduce the incidence of postpartum hemorrhage, increase comfort level in postpartum, promote postpartum recovery.
At present, conventional induced uresis method, Catheterization, acupuncture method comprised for the methods for the treatment of of puerpera's uroschesis in postpartum, refer to pressure diuresis cave method. Conventional induced uresis method such as hot compress, the principle of massaging, listen the revulsions such as the underwater sound be by massage pushing, reaching reflectivity stimulates detrusor urinae of bladder to shrink to cause and urinate, but less effective, and has the possibility causing bladder to break; The danger that puerpera is caused suffering and infects by Catheterization; Acupuncture is treated, is referred to the methods such as pressure diuresis cave, relatively bothers and requires efforts.
Summary of the invention
In view of the deficiencies in the prior art, it is an object of the invention to provide the pharmaceutical composition of a kind for the treatment of uroschesis in postpartum evident in efficacy. In order to realize the object of the present invention, contriver continues research on the basis of secret prescription handed down in the family from generation to generation and explores, and finally obtains following technical scheme:
Treating a pharmaceutical composition for uroschesis in postpartum, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: bark of official magnolia 23-30 part, cape jasmine 21-30 part, Fructus Sophorae 32-45 part, rhizoma zingiberis 6-10 part, Root of Medicinal Indian mulberry 6-12 part.
Preferably, the pharmaceutical composition for the treatment of uroschesis in postpartum as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: bark of official magnolia 25-27 part, cape jasmine 24-26 part, Fructus Sophorae 36-40 part, rhizoma zingiberis 7-9 part, Root of Medicinal Indian mulberry 8-10 part.
Further preferably, the pharmaceutical composition for the treatment of uroschesis in postpartum as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: the bark of official magnolia 26 parts, cape jasmine 25 parts, the Fructus Sophorae 38 parts, rhizoma zingiberis 8 parts, Root of Medicinal Indian mulberry 9 parts.
The application of a kind of pharmaceutical composition of the present invention in the externally applied medicine of preparation treatment puerpera's uroschesis in postpartum, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials by weight: the bark of official magnolia 23 parts, cape jasmine 30 parts, the Fructus Sophorae 32 parts, rhizoma zingiberis 6 parts, Root of Medicinal Indian mulberry 8 parts.
The application of a kind of pharmaceutical composition of the present invention in the externally applied medicine of preparation treatment puerpera's uroschesis in postpartum, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials by weight: the bark of official magnolia 30 parts, cape jasmine 21 parts, the Fructus Sophorae 40 parts, rhizoma zingiberis 10 parts, Root of Medicinal Indian mulberry 6 parts.
The application of a kind of pharmaceutical composition of the present invention in the externally applied medicine of preparation treatment puerpera's uroschesis in postpartum, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials by weight: the bark of official magnolia 25 parts, cape jasmine 25 parts, the Fructus Sophorae 45 parts, rhizoma zingiberis 8 parts, Root of Medicinal Indian mulberry 10 parts.
The pharmaceutical composition of fumigation in treating uroschesis in postpartum of the present invention can be prepared into powder, and method is: takes bark of official magnolia 23-30 part, cape jasmine 21-30 part, Fructus Sophorae 32-45 part, rhizoma zingiberis 6-10 part and Root of Medicinal Indian mulberry 6-12 part, cleans impurity elimination, dry, pulverize into particle, it is ground into smalls, packing.
Being found by multinomial experimental study and a large amount of clinical application, to clean after treatment the curative effect to puerpera's uroschesis in postpartum very remarkable by stifling for pharmaceutical composition of the present invention. Therefore, the 2nd object of the present invention is to provide a kind of pharmaceutical applications, and namely aforementioned pharmaceutical compositions treats the application in the externally applied medicine of puerpera's uroschesis in postpartum in preparation.
Compared with prior art, the pharmaceutical composition of the present invention adopts the stifling mode cleaned to be used for the treatment of uroschesis patient in postpartum, and its curative effect is very remarkable, apply also simple and easy to do, can avoiding being inserted urine pipe because of uroschesis, danger puerpera being caused suffering and infecting, more easily by patient is accepted; Reduce length of stay simultaneously, both relieved patient's soul pain, also mitigate the economical load of patient.
Embodiment
It should be noted that, traditional Chinese medicinal material raw materials of the present invention has following source: the bark of official magnolia selects the dry dry hide of Magnoliacea plant bark of official magnolia MagnoliaofficinalisRehd.etWils. or Magnolia bilola MagnoliaofficinalisRehd.etWils.var.bilobaRehd.etWils., Gen Pi and branch skin; Cape jasmine selects the dry mature fruit of madder wort cape jasmine GardeniajasminoidesEllis; The Fructus Sophorae selects the dry mature fruit of leguminous plants Chinese scholartree SophorajaponicaL.; Rhizoma zingiberis selects the dry rhizome of zingiber ZingiberofficinaleRosc.; Root of Medicinal Indian mulberry selects the dry root of madder wort Root of Medicinal Indian mulberry MorindaofficinalisHow.
The following is specific embodiments of the invention, the technical scheme of the present invention is done to be described further, but protection scope of the present invention is not limited to these embodiments. Every do not deviate from present inventive concept change or equivalent replacement include within protection scope of the present invention.
Embodiment 1
Crude drug prescription: the bark of official magnolia 0.26 kilogram, cape jasmine 0.25 kilogram, the Fructus Sophorae 0.38 kilogram, rhizoma zingiberis 0.08 kilogram, Root of Medicinal Indian mulberry 0.09 kilogram.
Preparation method: take above-mentioned Chinese medicinal materials, cleans impurity elimination, dries, pulverize into particle, be ground into smalls, by every bag of 100 grams of packing.
Embodiment 2
Crude drug prescription: the bark of official magnolia 0.23 kilogram, cape jasmine 0.3 kilogram, the Fructus Sophorae 0.32 kilogram, rhizoma zingiberis 0.06 kilogram, Root of Medicinal Indian mulberry 0.08 kilogram.
Preparation method: take above-mentioned Chinese medicinal materials, cleans impurity elimination, dries, pulverize into particle, be ground into smalls, by every bag of 100 grams of packing.
Embodiment 3
Crude drug prescription: the bark of official magnolia 0.3 kilogram, cape jasmine 0.21 kilogram, the Fructus Sophorae 0.4 kilogram, rhizoma zingiberis 0.1 kilogram, Root of Medicinal Indian mulberry 0.06 kilogram.
Preparation method: take above-mentioned Chinese medicinal materials, cleans impurity elimination, dries, pulverize into particle, be ground into smalls, by every bag of 100 grams of packing.
Embodiment 4
Crude drug prescription: the bark of official magnolia 0.25 kilogram, cape jasmine 0.25 kilogram, the Fructus Sophorae 0.45 kilogram, rhizoma zingiberis 0.08 kilogram, Root of Medicinal Indian mulberry 0.1 kilogram.
Preparation method: take above-mentioned Chinese medicinal materials, cleans impurity elimination, dries, pulverize into particle, be ground into smalls, by every bag of 100 grams of packing.
The clinical trial example of embodiment 5 treatment by Chinese herbs uroschesis in postpartum puerpera
There is childbirth puerpera 42 example of uroschesis in postpartum, the age 21-30 year, 26.1 ± 0.8 years old mean age, pregnant week in week 37-41, in average (38.7 ± 1.1) week, being unipara's row perineum side cutting art produces, and foundation-free is sick and protopathy. All puerperas are divided into control group (21 example) at random, and test group (21 example), two groups of there was no significant differences in age, pregnant cycle and the state of an illness etc., have comparability.
Two groups of puerpera's routines give to instruct postpartum, and control group adopts conventional processing, that is: abdominal massaging, vulva hot water injection, listen 30min flowing water sound induced uresis. Test group is aided with rapidly herbal fumigation on above-mentioned processed conventionally basis and cleans, and prescription consists of: bark of official magnolia 26g, cape jasmine 25g, Fructus Sophorae 38g, rhizoma zingiberis 8g, Root of Medicinal Indian mulberry 9g. Smoked washing method: Chinese medicinal materials prescription is decocted and boils 1.5 hours, remove decocting liquid 2L, the height of falling people pin cleans bedpan, bedpan is that a people one cleans with one, it is cooled to the stifling lOmin of about 45 DEG C airtight seat formulas, 13 example puerperas just urinate time stifling completely, and and then non-row person and non-emptying person clean 5-10min after fumigating and all can urinate completely. Concrete test-results is in table 1.
Table l control group and test group process effectiveness comparison (example)
Claims (2)
1. a pharmaceutical composition is in the application prepared in the externally applied medicine treating puerpera's uroschesis in postpartum, it is characterised in that: described pharmaceutical composition is prepared from by the traditional Chinese medicinal material raw materials of following weight part: the bark of official magnolia 25 parts, cape jasmine 25 parts, the Fructus Sophorae 45 parts, rhizoma zingiberis 8 parts, Root of Medicinal Indian mulberry 10 parts; Described pharmaceutical composition is herbal fumigation liniment.
2. pharmaceutical composition as claimed in claim 1 treats the application in the externally applied medicine of puerpera's uroschesis in postpartum in preparation, it is characterized in that: described pharmaceutical composition is obtained by following preparation method: take above-mentioned Chinese medicinal materials, clean impurity elimination, dry, pulverize into particle, it is ground into smalls, by every bag of 100 grams of packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610043474.3A CN105664094A (en) | 2014-02-28 | 2014-02-28 | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610043474.3A CN105664094A (en) | 2014-02-28 | 2014-02-28 | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410070799.1A Division CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105664094A true CN105664094A (en) | 2016-06-15 |
Family
ID=56302162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043474.3A Withdrawn CN105664094A (en) | 2014-02-28 | 2014-02-28 | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105664094A (en) |
-
2014
- 2014-02-28 CN CN201610043474.3A patent/CN105664094A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101015651A (en) | Medicine for treating protrusion of lumbar intervertebral disc | |
| CN103830697B (en) | A kind of pharmaceutical composition for the treatment of postpartum retention of urine | |
| CN102813900B (en) | External medicine for treating foot corns | |
| CN103301337B (en) | Traditional Chinese medicine for treating bovine puerperal fever | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN102600328B (en) | Fracture setting hot compress traditional Chinese medicine bag | |
| CN102204977B (en) | Preparation method and application of ointment composition for external use for treating tubal nowhere | |
| CN105664093A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN105664094A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN103908644A (en) | Plaster for stretching tendon and freeing waist and preparation method thereof | |
| CN108042622A (en) | A kind of Chinese medicine composition for treating osteoproliferation, arthralgia and preparation method thereof | |
| CN103285243B (en) | Granules for treating hyperglycemia | |
| CN106668604A (en) | Medicinal wine capable of dispersing pathogenic wind and strengthening yang and preparation method thereof | |
| CN101721588B (en) | Externally-applied traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN105641656A (en) | Medicine composition for treating postpartum uroschesis | |
| CN106806842A (en) | A kind of Chinese medicine composition for treating proliferation of mammary gland tubercle and preparation method thereof | |
| CN105688170A (en) | External traditional Chinese medicinal composition for treating stroke, preparation of external traditional Chinese medicinal composition and preparation method of external traditional Chinese medicinal composition | |
| CN103127226B (en) | Traditional Chinese medicine powder for treatment of burn and scald | |
| CN104815132A (en) | External lotion for treating low back and leg pain and preparation method | |
| CN103285361B (en) | Traditional Chinese medicine for treating horse orchitis | |
| CN103202994B (en) | A kind of charcoal fire medication technology for treating treating rheumatic ostealgia | |
| CN106492106A (en) | A kind of medicated wine of wind-damp dispelling and preparation method thereof | |
| CN107362342A (en) | A kind of combination medicament and preparation method for treating pelvic congestion syndrome | |
| CN104740590A (en) | Traditional Chinese medicine preparation used for calcanean spur syndrome and preparation method | |
| CN106038759A (en) | External medicinal wine for treating chronic strained lumbago, and preparation method of external medicinal wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Gu Ping Inventor after: Han Yanjun Inventor after: Dong Wenju Inventor before: Dong Wenju |
|
| CB03 | Change of inventor or designer information | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160615 |
|
| WW01 | Invention patent application withdrawn after publication |